Lorenz C Hofbauer
Overview
Explore the profile of Lorenz C Hofbauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
316
Citations
8622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofbauer L, Baschant U, Hofbauer C
J Clin Invest
. 2025 Mar;
134(12).
PMID: 40047888
Bone fracture healing is a complex process with distinct phases: the inflammatory phase, the soft and hard callus formation, and the remodeling phase. In older individuals, bone healing can be...
2.
Lossius-Cott C, Annoh A, Bens M, Nietzsche S, Hoffmann B, Figge M, et al.
JBMR Plus
. 2025 Feb;
9(3):ziae173.
PMID: 39906260
Activating internal tandem duplications (ITD) in the juxtamembrane domain of receptor tyrosine kinase FLT3 occur frequently in patients with acute myeloid leukemia (AML). Constitutive active FLT3-ITD mutations induce aberrant signaling...
3.
Daamouch S, Diendorfer A, Hackl M, Christoffel G, Hofbauer L, Rauner M
Front Endocrinol (Lausanne)
. 2025 Jan;
15():1477257.
PMID: 39777220
Type 1 diabetes (T1D) represents a significant health burden worldwide, with associated complications including bone fragility. Current clinical methods and biomarkers for assessing bone health and predicting fracture risk in...
4.
Carro Vazquez D, Emini L, Rauner M, Hofbauer C, Skalicky S, Wagner A, et al.
JBMR Plus
. 2024 Dec;
9(1):ziae121.
PMID: 39664932
Type 2 diabetes mellitus (T2DM) increases the susceptibility of bone fragility. The underlying mechanisms have, however, remained largely unknown. MicroRNAs (miRNAs) are short single-stranded non-coding RNA molecules with utility as...
5.
Tsourdi E, Gangler S, Kistler-Fischbacher M, Rauner M, Dawson-Hughes B, Orav E, et al.
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39657964
Context: Sclerostin inhibits canonical Wnt signaling, a pathway promoting bone formation. The effects of vitamin D3, omega-3 fatty acids (omega-3s), and exercise on serum sclerostin levels and bone metabolism are...
6.
7.
Passin V, Ledesma-Colunga M, Altamura S, Muckenthaler M, Baschant U, Hofbauer L, et al.
IUBMB Life
. 2024 Nov;
77(1):e2928.
PMID: 39555707
Iron is an essential element for physiological cellular processes, but is toxic in excess. Iron overload diseases are commonly associated with low bone mass. Increased bone resorption by osteoclasts as...
8.
Dogan D, Hornung I, Pettinato M, Pagani A, Baschant U, Seebohm G, et al.
FASEB J
. 2024 Nov;
38(22):e70179.
PMID: 39545682
Osteopenia is frequently observed in patients with iron overload, especially in those with HFE-dependent hereditary hemochromatosis (HH). Interestingly, not all mouse models of HH show bone loss, suggesting that iron...
9.
Clarke B, Khan A, Rubin M, Schwarz P, Vokes T, Shoback D, et al.
J Clin Endocrinol Metab
. 2024 Oct;
PMID: 39376010
Context: Conventional therapy for hypoparathyroidism aims to alleviate symptoms of hypocalcemia but does not address insufficient parathyroid hormone (PTH) levels. Objective: Assess the long-term efficacy and safety of TransCon PTH...
10.
Weidner H, Baschant U, Ledesma-Colunga M, Basiak K, Tsourdi E, Sockel K, et al.
Leukemia
. 2024 Jun;
38(8):1853-1857.
PMID: 38906963
No abstract available.